Login / Signup

GPER-1 expression is associated with a decreased response rate to primary tamoxifen therapy of breast cancer patients.

Tanja IgnatovOliver TreeckThomas KalinskiOlaf OrtmannAtanas Ignatov
Published in: Archives of gynecology and obstetrics (2020)
GPER-1 expression is significantly associated with a reduced effect of primary treatment with tamoxifen in breast cancer patients.
Keyphrases
  • estrogen receptor
  • poor prognosis
  • breast cancer cells
  • positive breast cancer
  • stem cells
  • combination therapy
  • replacement therapy